Abbott Laboratories announces a 7.4% sales increase to $11.14 billion in Q2 2025, with operating earnings up by 23% and net earnings growing by 36.7%. CEO Robert B. Ford highlights...
Abbott Laboratories reports a 4% increase in Q1 2025 revenue to $10.4B and an 8.2% rise in net earnings to $1.3B, with EPS up by 8.6%. CEO Robert Ford highlights the company's dive...
Abbott Laboratories reports a 4% revenue increase to $10.4 billion and an 8.2% rise in net earnings to $1.3 billion in Q1 2025, with CEO Robert Ford highlighting the strength of it...
Abbott Laboratories reports a strong start to 2025 with a 4% revenue increase to $10.4 billion and an 8.2% rise in net earnings to $1.3 billion in Q1, alongside reaffirmed 2025 gro...
